Vanguard Pharma Corporation
Defense & Aerospace · Lobbying Client
C
Influence Score
45/100
Moderate Influence
$2.7M
Total Lobby Spend
5
Policy Issues
1
Lobbyists
0
Revolving Door
Vanguard Pharma Corporation reported $2.7 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Defense, Aerospace, Budget/Appropriations. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Centers for Medicare & Medicaid Services
Dept of Commerce
Securities & Exchange Commission
Dept of Health & Human Services
Federal Energy Regulatory Commission
Dept of Agriculture
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | BGR Group LLP | FIRAERDEF | 1 | $195K |
| 2020 Apr-Jun | K&L Gates LLP | FIR | 1 | $161K |
| 2020 Jul-Sep | Holland & Knight LLP | AERDEF | 1 | $162K |
| 2020 Oct-Dec | Brownstein Hyatt LLP | BUDDEFFIR | 1 | $159K |
| 2021 Jan-Mar | Brownstein Hyatt LLP | DEF | 1 | $89K |
| 2021 Apr-Jun | BGR Group LLP | FIR | 1 | $71K |
| 2021 Jul-Sep | Akin Gump LLP | DEFGOV | 1 | $101K |
| 2021 Oct-Dec | Holland & Knight LLP | AERGOVFIR+2 | 1 | $72K |